Teva Pharmaceuticals USA, Inc. ex rel. Gate Pharmaceuticals Division v. Eisai Co.

Federal Circuit

Teva Pharmaceuticals USA, Inc. ex rel. Gate Pharmaceuticals Division v. Eisai Co.

426 F. App'x 904

CourtCourt of Appeals for the Federal Circuit

DecidedJuly 21, 2011

DocketNo. 2009-1593

StatusPublished

This text of 426 F. App'x 904 (Teva Pharmaceuticals USA, Inc. ex rel. Gate Pharmaceuticals Division v. Eisai Co.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Teva Pharmaceuticals USA, Inc. ex rel. Gate Pharmaceuticals Division v. Eisai Co., 426 F. App'x 904 (Fed. Cir. 2011).

Pincite

Opinion

ORDER

Upon consideration of the order of the Supreme Court of the United States in Eisai Co., Ltd., et al. v. Teva Phamaceuticals USA, Inc. Through its Gate Pharmaceuticals Division, — U.S. -, 131 S.Ct. 2991, 180 L.Ed.2d 818 (2011), vacating this court’s judgment,

It is Ordered That:

(1) The mandate of this court issued on December 13, 2010 is recalled, the appeal is reinstated, and this court’s October 6, 2010 judgment is vacated.

(2) The appeal is remanded to the district court with instructions to dismiss the complaint as moot.

Free access — add to your briefcase to read the full text and ask questions with AI